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Increasing 
Incidence of 
Nontuberculous 
Mycobacteria, 
Taiwan, 2000–2008 
To the Editor: Lai et al. (1) re-
ported an increase in the number of 
nontuberculous mycobacteria (NTM) 
isolates and patients with pulmonary 
NTM diseases after implementation of 
the BACTEC system (Becton Dickin-
son, Sparks, MD, USA) late in 2001. 
These authors also reported that the in-
crease was mainly in persons infected 
with Mycobacterium avium complex 
(MAC) and M. abscessus. They stated 
that diseases caused by NTM were 
deﬁ  ned according to current diagno-
sis criteria published in 2007 (2). This 
ﬁ  nding suggests that Lai et al. were 
able to review the clinical and radio-
logic information for all patients.
We wonder whether they were 
also able to identify and exclude peo-
ple with NTM colonization, i.e., per-
sons with positive cultures for NTM 
who did not meet the American Tho-
racic Society disease criteria. It would 
have been interesting to know the 
trend in colonized persons. In a previ-
ous study from British Columbia (3), 
we found an increase in the number of 
NTM isolates mostly in persons with 
MAC colonization. This ﬁ  nding coin-
cided with implementation of a new 
laboratory technique in 2000, which 
suggested that the new technology is 
more sensitive in detecting MAC. In 
contrast with the ﬁ   ndings of Lai et 
al., our study from British Columbia 
showed that the incidence in patients 
treated for NTM pulmonary disease 
(the group used as a surrogate of NTM 
disease) has been decreasing over 
time, which is reassuring.
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In Response: We thank Hernán-
dez-Garduño and Elwood for drawing 
attention to the issue of nontubercu-
lous mycobacteria (NTM) coloniza-
tion (1), which was not described in 
our study (2). Among 4,786 patients 
with NTM isolates treated at our hos-
pital during 2000–2008, colonization 
was found in 76.9% (3,681), and only 
23.1% (1,105) had NTM diseases ac-
cording to the criteria of the American 
Thoracic Society and Infectious Dis-
eases Society of America (3).
Annual proportions of NTM iso-
lates causing colonizations ranged 
from 29.2% in 2001 to 19.8% in 2007. 
During the study period, annual in-
cidences of NTM colonization and 
disease increased from 6.6/100,000 
inpatients and 2.7/100,000 outpatients 
in 2000 to 34.5/100,000 inpatients and 
10.2/100,000 outpatients in 2008. My-
cobacterium avium complex (MAC) 
was the most prevalent species, colo-
nizing 1,282 (34.8%) of 3,681 patients. 
Annual proportions of MAC isolates 
causing colonization ranged from 
20.0% in 2000 to 12.6% in 2006. An-
nual incidence of MAC colonization 
increased from 1.9/100,000 inpatients 
in 2000 to 12.3/100,000 inpatients 
in 2008; incidence of MAC disease 
also increased from 0.5/100,000 in-
patients in 2000 to 2.1/100,000 in-
patients in 2008. M. abscessus, the 
second most common species in our 
study (2), caused colonization and 
disease in 669 and 155 patients, re-
spectively. Annual incidence of M. 
abscessus colonization and infection 
also increased from 1.49/100,000 in-
patients and 0.3/100,000 outpatients 
in 2000 to 7.0/100,000 inpatients and 
1.9/100,000 outpatients in 2008.
Our study and a previous study 
in British Columbia (4) suggest that 
improvement in diagnostic methods 
would detect increased incidence of 
NTM, especially of MAC; most iso-
lates identiﬁ  ed in these studies were 
associated with colonization. We also 
demonstrated a gradual increase in the 
incidence of all NTM, MAC, and M. 
abscessus over time in Taiwan, which 
may be attributable to increasing vigi-
lance and awareness of these bacteria 
as human pathogens and the increased 
population of immunocompromised 
patients. Thus, clinicians should con-
sider diagnosing NTM diseases with 
sensitive and advanced laboratory 
methods because of the increasing 
population of patients at risk.
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Food Reservoir for 
Escherichia coli 
Causing Urinary 
Tract Infections
To the Editor: We read with in-
terest the article by Vincent et al. that 
compared  Escherichia coli isolates 
from 3 sources (human urinary tract 
infections [UTIs], retail meat, and res-
taurant/ready-to-eat foods) by multiple 
molecular typing methods (1). This 
study has to be considered in the con-
text of the larger debate about the pos-
sible animal origin of E. coli isolates 
that cause extraintestinal infections in 
humans (2–5), and the same authors 
(Vincent et al.) have declared, in the 
introduction, that their efforts were 
directed toward investigating the hy-
pothesis that retail chicken is the main 
reservoir for extraintestinal E. coli.
We strongly appreciate the 
amount of the experimental data and 
some interesting ﬁ  ndings, but we are 
not totally convinced of the authors’ 
conclusions, particularly the assump-
tion that the study strongly supports 
the preliminary hypothesis. First, the 
observation that only a low proportion 
(73/844, 8.6%) of the E. coli isolates 
analyzed belonged to clonal groups 
(deﬁ  ned as >2 E. coli isolates that had 
indistinguishable multilocus variable 
number tandem repeats and enter-
obacterial repetitive intergenic con-
sensus 2 patterns), including members 
from >1 source, suggests an overall 
high degree of genetic heterogeneity 
among isolates from different sources. 
Second, looking at the single isolates 
within clonal groups reported in Table 
2, twelve (2.9%) of the 417 isolates 
from retail meat shared multilocus 
variable number tandem repeats, en-
terobacterial repetitive intergenic 
consensus 2, and multilocus sequence 
types with some human UTI iso-
lates; however, only 1 isolate (strain 
EC01DT06–1737–01) was also found 
to be indistinguishable from a human 
isolate (strain MSHS 161) by pulsed-
ﬁ   eld gel electrophoresis , indicating 
that identical genotypes (between iso-
lates from retail meat and human in-
fections) were observed only once.
Although we agree that the ﬁ  nd-
ing of a partial overlap between mul-
tilocus sequence types of isolates 
from retail meat and from human UTI 
isolates is noteworthy (especially re-
covery of an ST131 isolate of avian 
origin), the emphasis posed for the 
role of food transmission in the dis-
semination of the E. coli strains that 
cause community-acquired UTIs, in 
our opinion, does not seem strongly 
supported by the experimental data. 
Nevertheless, the topic is relevant, and 
we would highlight the importance of 
further research on this issue.
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